1.Evaluation of Consultation with Young Patients with Cancer and their Children in Hospice Palliative Care During Infancy, Childhood, and Adolescence
Eun Ju PARK ; Kwonoh PARK ; So Yeon OH
Health Communication 2019;14(1):11-15
BACKGROUND: In this study, consultations with children of young patients with cancer were evaluated by dividing the child's age into infancy, childhood, and adolescence to ensure the necessity and importance of appropriate intervention, coordination, and communication.METHODS: From June 2017 to February 2019, medical records and consultation records were reviewed by selecting suitable cases among patients hospitalized in hospice palliative care unit at a Pusan national university Yangsan hospital. The consultation was conducted on several occasions by nurses, doctors and social workers from the time the patient was hospitalized to the day before death.RESULTS: The cases of consultation were as follows: female patient with stomach cancer with a child in infancy, patient with gastric cancer with a child in childhood, and male patient with rectal cancer with a child in adolescence.CONCLUSION: It is ideal for parents to initiate communication with their children on their terminal status, so multidisciplinary teams must first support the motivation. In consultations with children, we should first explain the information about the cancer status of the parents, followed by the future clinical course, estimated life expectancy, and changes related to terminal status. Additionally, we must attempt to manage the psychological and emotional concerns of children. This study may support the creation of an atmosphere for in-depth research on family interviews of young patients with cancer in Korea. We think that this will contribute as basic data for some guidelines for communication based on the age of children in consultations with patients with terminal cancer.
Adolescent
;
Atmosphere
;
Busan
;
Child
;
Female
;
Gyeongsangnam-do
;
Hospice Care
;
Hospices
;
Humans
;
Korea
;
Life Expectancy
;
Male
;
Medical Records
;
Motivation
;
Palliative Care
;
Parents
;
Rectal Neoplasms
;
Referral and Consultation
;
Social Work
;
Social Workers
;
Stomach Neoplasms
;
Young Adult
2.Safety and Efficacy of Peripherally Inserted Central Catheters in Terminally Ill Cancer Patients: Single Institute Experience.
Kwonoh PARK ; Hyoung Gun LIM ; Ji Yeon HONG ; Hunho SONG
Korean Journal of Hospice and Palliative Care 2014;17(3):179-184
PURPOSE: We investigated the safety and efficacy of peripherally inserted central catheters (PICCs) in terminally ill cancer patients. METHODS: A retrospective review was conducted on patients who underwent PICC at the hospice-palliative division of KEPCO (Korea Electric Power Corporation) Medical Center between January 2013 and December 2013. All PICCs were inserted by an interventional radiologist. RESULTS: A total of 30 terminally ill cancer patients received the PICC procedure during the study period. Including one patient who had had two PICC insertions during the period, we analyzed a total of 31 episodes of catheterization and 571 PICC days. The median catheter life span was 14.0 days (range, 1~90 days). In 25 cases, catheters were maintained until the intended time (discharge, transfer, or death), while they were removed prematurely in six other cases (19%; 10.5/1000 PICC days). Thus, the catheter maintenance success rate was 81%. Of those six premature PICC removal cases, self-removal due to delirium occurred in four cases (13%; 7.0/1000 PICC days), and catheter-related blood stream infection and thrombosis were reported in one case, each (3%; 1.8/1000 PICC days). Complication cases totaled eight (26%; 14.1/1000 PICC days). The time to complication development ranged from two to 14 days and the median was seven days. There was no PICC complication-related death. CONCLUSION: Considering characteristics of terminally ill cancer patients, such as a poor general condition, vulnerability to trivial damage, and a limited period of survival, PICC could be a safe intravenous procedure.
Catheterization
;
Catheterization, Central Venous
;
Catheterization, Peripheral
;
Catheters*
;
Delirium
;
Hospice Care
;
Humans
;
Palliative Care
;
Retrospective Studies
;
Rivers
;
Terminal Care
;
Terminally Ill*
;
Thrombosis
3.Diffuse Large B-Cell Lymphoma Transformed from a Rectal Mucosa-Associated Lymphoid Tissue Lymphoma.
Sae Han KANG ; Jang Won PARK ; Byung Wook JUNG ; Jun Gyu SONG ; Hyun Sik OH ; Kwonoh PARK
The Ewha Medical Journal 2016;39(2):51-55
Primary rectal lymphoma is a rare disease among the gastrointestinal (GI) lymphoma. In particular, diffuse large B-cell lymphoma (DLBCL) transformed from mucosa-associated lymphoid tissue (MALT) lymphoma is often the primary type of GI lymphoma, mostly in stomach or duodenum, but has never been reported in rectum. Here we report an unusual case in which a 75-year-old male patient diagnosed with DLBCL transformed from MALT lymphoma in the rectum. The patient was diagnosed as rectal DLBCL transformed from MALT lymphoma as Lugano stage II2 and was treated with chemotherapy (R-CHOP) with CD-20 monoclonal antibody (rituxaimb). Complete remission of multiple lymphadenopathy and mass forming ulcer of the rectum was achieved after 6 cycles of R-CHOP. He has been free from disease for 12 months.
Aged
;
B-Lymphocytes*
;
Drug Therapy
;
Duodenum
;
Humans
;
Lymphatic Diseases
;
Lymphoid Tissue
;
Lymphoma
;
Lymphoma, B-Cell*
;
Lymphoma, B-Cell, Marginal Zone*
;
Male
;
Rare Diseases
;
Rectum
;
Stomach
;
Ulcer
4.Advance Directives for Advanced Cancer Patients in Oncology Department: Single Center Experience.
Byung Wook JUNG ; Jun Gyu SONG ; Sae Han KANG ; Byung Woo YOON ; Yonggeon SONG ; Kwonoh PARK
The Ewha Medical Journal 2016;39(4):104-109
OBJECTIVES: Advance directives (AD) are designed to protect patients’ autonomy and self-determination, which mean the end of life care planning should precede before loss of their decision ability. We aimed to analyze our experience of AD at field of oncology, focusing on preference of end-of-life care and outcome in advanced cancer patients. METHODS: A retrospective review was conducted on advanced cancer patients who underwent AD at the department of Oncology of Hanil General Hospital, between April 2013 and January 2014. AD are composed of decision about end of life care (resuscitation, ventilator, artificial tube feeding) and determination of proxy. RESULTS: Among 23 patients who were recommended AD during study period, 19 patients (83%) successfully underwent AD. The median age was 67 years (range, 50 to 95 years) and male was predominance (84%) was observed. Most of them (90%) have not heard of AD in the past. With regard to decision of end-of-life care, decision for resuscitation and ventilator were selected only by 1 patient (5%), respectively, while 10 patients (52%) decided to receive tube feeding. Among 5 patients who underwent AD during chemotherapy, there was neither transfer to other hospital for anti-cancer treatment nor follow up loss. CONCLUSION: AD might be applicable in advanced cancer patients at field of oncology, including also patients treated with palliative chemotherapy.
Advance Directives*
;
Drug Therapy
;
Enteral Nutrition
;
Follow-Up Studies
;
Hospitals, General
;
Humans
;
Male
;
Proxy
;
Resuscitation
;
Retrospective Studies
;
Terminal Care
;
Ventilators, Mechanical
5.Pulmonary Tumor Thrombotic Microangiopathy Associated with Advanced Gastric Cancer Successfully Treated with Chemotherapy.
Seung Hyun YOO ; Kwonoh PARK ; Ji Yeon HONG ; Ji Yeon KIM ; Jang Won PARK ; Yong Won PARK ; Kyung Hun LEE ; Kyung So JEON
The Ewha Medical Journal 2014;37(2):146-151
Pulmonary tumor thrombotic microangiopathy (PTTM) is an uncommon and fatal malignancy-related pulmonary complication characterized by fibrocellular intimal proliferation of small pulmonary arteries and arterioles. It causes marked pulmonary hypertension, right-side heart failure, and sudden death. Diagnosis of PTTM is extremely difficult while the patient is alive. Here, we report a 44-year-old woman who presented with complaining of progressing dyspnea and pulmonary hypertension but with no history of cancer. She was diagnosed with PTTM caused by advanced gastric cancer ante mortem and was treated effectively with chemotherapy.
Adult
;
Ants
;
Arterioles
;
Death, Sudden
;
Diagnosis
;
Drug Therapy*
;
Dyspnea
;
Female
;
Heart Failure
;
Humans
;
Hypertension, Pulmonary
;
Pulmonary Artery
;
Stomach Neoplasms*
;
Thrombotic Microangiopathies*
6.A Case of a Cytomegalovirus Colitis Related Rectal Stricture Treated by Endoscopic Balloon Dilation.
Kwonoh PARK ; Kyung Ho KIM ; Jong Won PARK ; Sangho LEE ; Hyunjung JO ; Seungyun CHUN ; Hyewon PARK ; Hak Yang KIM
Korean Journal of Gastrointestinal Endoscopy 2010;41(4):240-244
Cytomegalovirus (CMV) colitis is a common opportunistic infection in immunocompromised patients. Affected individuals present with abdominal pain, diarrhea, or hematochezia. Complications of CMV colitis can include massive bleeding, toxic megacolon, bowel perforation and, rarely, colon stricture. A 69-year-old woman who had no specific past history was admitted to the orthopedic department for pelvic bone fracture with right iliac artery rupture caused by a traffic accident. She was successfully managed with emergency transarterial coil embolization. After 2 weeks, she developed hematochezia and recurrent abdominal pain. Colonoscopy showed a huge, deep ulcer in the rectosigmoid colon. Biopsy and immunohistochemical staining revealed giant cells with intracellular inclusion bodies that were positive for CMV antigen. She received antiviral treatment after which her symptoms improved. On follow-up colonoscopy 3 months later, we found a tight luminal narrowing in the rectum. We did a repeat endoscopic balloon dilation in this patient and she experienced improvement.
Abdominal Pain
;
Accidents, Traffic
;
Aged
;
Biopsy
;
Colitis
;
Colon
;
Colonoscopy
;
Constriction, Pathologic
;
Cytomegalovirus
;
Diarrhea
;
Emergencies
;
Female
;
Follow-Up Studies
;
Gastrointestinal Hemorrhage
;
Giant Cells
;
Hemorrhage
;
Humans
;
Iliac Artery
;
Immunocompromised Host
;
Inclusion Bodies
;
Megacolon, Toxic
;
Opportunistic Infections
;
Orthopedics
;
Pelvic Bones
;
Phenobarbital
;
Rectum
;
Rupture
;
Ulcer
7.A Case of a Pulmonary Arteriovenous Malformation With Ebstein's Anomaly.
Kwonoh PARK ; Changhwan KIM ; Dal Soo LIM ; Young Moo RO ; Jongwon PARK ; Seungyun CHUN ; Seungjin LIM ; Hyunjung CHO ; Sangho LEE ; Sung Eun KIM
Korean Circulation Journal 2010;40(12):684-686
A pulmonary arteriovenous malformation (PAVM) is a rare pulmonary vascular anomaly presenting as dyspnea or recurrent epistaxis. Ebstein's anomaly (EA), a congenital cardiac malformation, is also a rare condition. There have been no reports concerning the co-existence of PAVM with hereditary hemorrhagic telangiectasia (HHT) and EA. A 40-year-old woman was admitted with a 2-month history of increasing dyspnea and several years of recurrent epistaxis. On transthoracic echocardiography, she was diagnosed with EA and agreed to undergo surgical treatment. A chest CT angiography showed a 12-mm serpiginous vascular structure suspicious for a PAVM and a liver CT suggested HTT. Although it is unclear whether or not a concurrent PAVM and EA have an embryologic or genetic relationship, we report a case of a PAVM with EA. Further genetic and embryonic studies are needed to identify a possible relationship of the two medical conditions.
Adult
;
Angiography
;
Arteriovenous Malformations
;
Dyspnea
;
Ebstein Anomaly
;
Echocardiography
;
Epistaxis
;
Female
;
Humans
;
Liver
;
Lung
;
Telangiectasia, Hereditary Hemorrhagic
;
Thorax
8.Safety and Effectiveness of Indwelling Percutaneous Drainage in Hospitalized Terminally Ill Cancer Patients with Recurrent Ascites
Kwonoh PARK ; Geon Woo LEE ; Jae-Joon KIM ; Sang-Bo OH ; So Yeon OH ; Eun-Ju PARK ; Jin Hyeok KIM ; Joo Yeon JANG ; Ung-Bae JEON
The Ewha Medical Journal 2020;43(2):29-34
Objectives:
Terminally ill cancer patients in hospice palliative care unit are reluctant to undergo repetitive invasive procedures due to coagulopathies and poor performance or condition, while catheter management such as regular irrigation during hospitalization is easy. The purpose of this study was to investigate the safety and efficacy of indwelling intraperitoneal (IP) catheter in hospitalized terminally ill cancer patients with recurrent ascites.
Methods:
A retrospective review was conducted in patients who underwent IP catheter at the hospice palliative care unit of Pusan National University Yangsan Hospital between August 2016 and June 2018. All catheters were inserted by interventional radiologists with radiological guidance. The primary end-points were functional IP catheter maintenance rate, which is catheter maintained with patency for drainage until the intended time.
Results:
A total of 25 terminally ill cancer patients underwent IP catheters placements during the study period. All catheters were successfully inserted without major complications, but one patient had trivial bleeding and one other patient had temporary pain. The median time from admission to catheter insertion was 5 days (range, 1 to 49 days). Twenty-one catheters were maintained with function until the intended time, three cases were maintained without function, and the last one was removed early due to obstruction and pain. Finally, the functional IP maintenance rate was 84% (21/25) and the median functional catheter life span was 15 days (95% confidence interval, 10.8 to 17.2).
Conclusion
Our study showed relatively favorable results for IP catheter maintenance and safety in hospitalized terminally ill cancer patients with malignant ascites.
9.Clinical Characteristics, Treatment Delivery, and Cisplatin Eligibility in Korean Patients Initially Diagnosed with Urothelial Carcinoma
Kwonoh PARK ; Jong Kil NAM ; Bon Jin KOO ; Hyun Jung LEE ; Tae Un KIM ; Hwaseong RYU ; Yun Jeong HONG ; Seungsoo LEE ; Dong Hoon LEE ; Sung Woo PARK
The Ewha Medical Journal 2021;44(3):63-69
Objectives:
The aim of this study was to examine the clinical presentation, treatment delivery, and cisplatin eligibility of Korean patients with urothelial carcinoma (UC) in a real-world setting.
Methods:
We performed a retrospective cohort study of patients initially diagnosed with UC from March 2013 to June 2018. Creatinine clearance >60 mL/min and Eastern Cooperative Oncology Group performance status (0–1) were adopted as cisplatin eligibility criteria.
Results:
This study included 557 eligible patients. Median age was 71.0 years (range, 33–94 years), and males were dominant (80%). Primary tumor sites were: upper genitourinary tract, 18%; bladder, 81%; and urethra, 0.4%. Initial disease status was non-muscle invasive bladder cancer (313, 56%), diffuse infiltrating non-muscle invasive bladder cancer (19, 3%), cTanyN0 upper tract UC (75, 13%), cT2-4N0 bladder UC (82, 15%), TanyN1-3 UC (36, 7%), or initially metastatic UC (32, 6%). At the time of analysis (June 2019), following treatments were delivered to 134 patients with localized UC: radical operation with or without perioperative treatment (89, 67%), definitive chemoradiation (7, 5%), and palliative surgery or supportive care only (36, 28%). In total, 89 patients had metastatic UC, including those with recurrent disease (n=57), and 34 (38%) of the 89 were eligible for cisplatin.
Conclusion
Clinical presentations in East Asian UC patients were consistent with those of previous studies in other countries, except for a relatively high incidence of upper genitourinary tract. Our results can serve as a benchmark for further advances and future research for treatments of UC in East Asian patients.
10.Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice
Kwonoh PARK ; Jin Young KIM ; Inkeun PARK ; Seong Hoon SHIN ; Hyo Jin LEE ; Jae Lyun LEE
Yonsei Medical Journal 2023;64(2):86-93
Purpose:
Evidence in favor of adding docetaxel in treatment of metastatic hormone-sensitive prostate cancer (mHSPC) has led to docetaxel in conjunction with androgen deprivation therapy (ADT) as standard therapy. The aim of this study was to examine the effectiveness of docetaxel with ADT for Korean patients with mHSPC in real-world practice.
Materials and Methods:
A retrospective cohort study was performed at six Korean hospitals for patients with mHSPC treated with docetaxel plus ADT. Patients were treated every 3 weeks for up to six cycles with 75 mg/m 2 of docetaxel. The primary endpoint was time to castration resistant prostate cancer (CRPC).
Results:
This study included 46 eligible patients from June 2016 to February 2021. Median age was 68.5 years (range, 52–84) and all patients present with de novo M1 with high-volume disease. The median prostate-specific antigen (PSA) level at ADT initiation was 205.4 (7.7–1933) ng/mL, and time from ADT to docetaxel was 2.4 months (0–5.3). All six planned cycles of docetaxel were delivered in 36 patients (78%), 7 patients (15%) discontinued treatment due to adverse events, and 3 patients (7%) discontinued due to progression. At the time of the analysis, CRPC had developed in 34 patients (74%), and the median time to CRPC was 18.0 (95% confidence interval, 14.1–21.9) months. PSA <0.2 ng/mL was achieved in 11 patients (24%) after 6 months of ADT and in 10 patients (22%) after 12 months. At last follow-up, 35 patients (76%) were alive; the median overall survival was not reached.
Conclusion
The effect of docetaxel combined with ADT for Korean patients with mHSPC is comparable with prior results in Western studies.